Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516265 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
ElectronicAdd to Basket
Live Chat Live Help Software for Website

Pharmaceutical Lifecycle Management: Strategy Selection and Execution

Cutting Edge Information, Oct 2010, Pages: 152


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

As short-term concerns naturally dominate commercial activity, lifecycle management (LCM) is a keystone to strategic, long-term brand planning. Faced with shrinking market exclusivity, evolving branded competitors, aggressive generics and, overall, less time to recoup investments drug companies devise robust strategies to prolong brand life and value.

Successful teams plan carefully and give themselves plenty of time to execute their strategies, which may take years to bear fruit. In best-case scenarios, centralized LCM groups collaborate across functions to knock down silos and focus all stakeholders on long-term brand success.
Empower your lifecycle management team and track the effectiveness of different LCM strategies:

- Build LCM expertise: Track benchmarks for dedicated LCM teams as they plan, execute and review their strategies. Explore real-company approaches to LCM structure, see how leading companies eliminate structural silos to strengthen cross-functional coordination.

- Master LCM’s driving factors: Understand the critical factors steering LCM efforts, including management buy-in, leadership and resources. Inform your strategy with profiles of 11 key tactic, complete with ROI, timing and effectiveness data.

- Show ROI and win buy-in: Learn LCM veterans’ approaches to addressing the ROI challenge and see how they justify LCM activities and funding.

The four chapters in Pharmaceutical Lifecycle Management include benchmarks that detail lifecycle management team (LCM) structure, strategy-setting and leadership. Other metrics explore timing, budget and effectiveness of 11 specific LCM strategies.

Chapter 1: Incorporating Lifecycle Management into the Marketing Organization

16 data charts detailing LCM structure and reporting lines:
- Functions overseeing LCM efforts
- Specific examples of LCM organizational structure
- Level of executive leadership overseeing LCM activities
- LCM activities performed by specific functions

Chapter 2: Lifecycle Management Budgets and ROI

24 data charts focused on the following:

LCM strategy-setting and budgeting
- Departments determining spending per brand
- Functions contributing to overhead LCM costs
- Average percentages of US and EU revenue lost in first year of generic competition

Measuring ROI and effectiveness of LCM initiatives
- Impact of historical ROI metrics on strategy decisions
- Self-rating of factors affecting LCM groups:
- Understanding of threats and opportunities
- Level of resources and funding
- Level of communication and knowledge
- Ability to collaborate across business functions
- Grasp of strategic timing for activities
- Ability to implement initiatives
- Effectiveness of executed LCM tactics

Impact of market threats on LCM plans
- Patent litigation challenges
- New branded market competitors
- Managed care and formulary access challenges
- Price wars
- Scientific development limitations

Chapter 3: Strategic Considerations for Lifecycle Management Plans

18 data charts focused on these topics:

The importance placed on different factors when setting or executing LCM strategy:
- Potential return on investment
- Market research findings
- Competitors’ strategy
- Past experiences in setting strategy
- Execution cost and time
- Time from patent expiration

The impact of specific factors when executing LCM strategies:
- Senior management buy-in
- Strong leadership
- Cross-functional collaboration
- Core LCM team continuity
- Adequate resources and time
- Proactive planning
- Previous experience
- Knowledge management efficiency

Chapter 4: Assessment of Lifecycle Management Tactics

74 data charts that comprise profiles for 11 key LCM tools:
- New indications
- New formulations
- Pediatric market exclusivity
- Disease management programs
- Strategic pricing changes
- Authorized generics
- Combination products
- Next-generation products
- New dosing regimens
- Patent litigation
- Rx-to-OTC switches

Charts break down timing, budget and effectiveness metrics for each tactic above:
- Amount of time needed to best implement specific tactic
- Additional dollars earned per dollar spent on specific strategy
- Phases in which tactic is planned and executed
- Number of years left on patent when tactic execution begins
- Time spent implementing the tactic
- Ideal timeline for implementing the tactic


Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Lifecycle Management Strategies - Key Tools to Maximize Return on Investment in a Tough Healthcare Environment

Sustained Release Injectables: Evolving Formulations, Improving Dosing Regimens

U.S. Healthcare Reform: Impact on the Pharmaceutical Industry

Healthcare Market Access Management: Building Teams that Deliver Value to Payers

Guide to Patient-Centered Case Management - Revised 2011 Edition

All Change in the US Pharma Market?

Health Economics and Outcomes Research: US, Europe, Canada & Emerging Markets

2011 Benchmarks in Healthcare Case Management: Responsibilities, Results & ROI

Medical Device Branding - Building Identity and Equity

Trends in Pharmaceutical Portfolio Management - Strategies to maintain profitability despite adversity



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds